Dr Frank McCaughan and student, Dr Phil Barry, miniaturised a human cell-based model of early-stage lung cancer enabling the assay to replace some drug screening experiments using mice.
631 results
Principal Investigator: Dr Richard van Arkel, Imperial College London
Principal Investigator: Dr Gowsihan Poologasundarampillai, University of Birmingham
Principal Investigator: Dr Peter Rugg-Gunn, Babraham Institute Cambridge
Principal Investigator: Dr Inés Cebola, Imperial College London
Principal Investigator: Dr Anna Krasnodembskaya, Queen's University Belfast
Principal Investigator: Dr Michael Colman, University of Leeds
Principal Investigator: Dr Gabriel Galea, University College London
Current contact: Dr Ellen Forty
Current contact: Dr Elliot Lilley
Professor Cathy Merry has developed synthetic hydrogels that support 3D culture for multiple cell types and used NC3Rs funding to support their application across multiple scientific disciplines.
Dr Karl Butterworth and PhD Student Dr Kathryn Brown have applied high precision cancer radiotherapy techniques used to treat human patients to improve the reproducibility and translatability of preclinical animal trials.
Dr Paola Campagnolo has used NC3Rs funding from a Project grant and a Skills and Knowledge Transfer award to develop an ex vivo model of the epicardium to replace the use of mice for high throughput screening of cardiac therapies in academia and industry.
Principal Investigator: Professor Deborah Mason, Cardiff University
Principal Investigator: Professor Robert Hindges, King's College London
Principal Investigator: Dr Jonathan Ball, University of Exeter
Principal Investigator: Dr David Dickens, University of Liverpool
Principal Investigator: Professor Awen Gallimore, Cardiff University
Principal Investigator: Dr Laura Randle, University of Liverpool
Principal Investigator: Professor Manuel Mayr, Imperial College London
